Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

144 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets.
Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Konstantinopoulos PA, et al. Nat Rev Drug Discov. 2007 Jul;6(7):541-55. doi: 10.1038/nrd2221. Nat Rev Drug Discov. 2007. PMID: 17585331 Review.
Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.
Zachos I, Konstantinopoulos PA, Tzortzis V, Gravas S, Karatzas A, Karamouzis MV, Melekos M, Papavassiliou AG. Zachos I, et al. Among authors: konstantinopoulos pa. Expert Opin Investig Drugs. 2010 Jul;19(7):875-87. doi: 10.1517/13543784.2010.496450. Expert Opin Investig Drugs. 2010. PMID: 20528482 Review.
The potential of proteasome inhibition in the treatment of colon cancer.
Konstantinopoulos PA, Papavassiliou AG. Konstantinopoulos PA, et al. Expert Opin Investig Drugs. 2006 Sep;15(9):1067-75. doi: 10.1517/13543784.15.9.1067. Expert Opin Investig Drugs. 2006. PMID: 16916273 Review.
Chromatin-modulating agents as epigenetic anticancer drugs--'the die is cast'.
Konstantinopoulos PA, Papavassiliou AG. Konstantinopoulos PA, et al. Drug Discov Today. 2006 Feb;11(3-4):91-3. doi: 10.1016/S1359-6446(05)03713-X. Drug Discov Today. 2006. PMID: 16533705 No abstract available.
Targeting MET as a strategy to overcome crosstalk-related resistance to EGFR inhibitors.
Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Karamouzis MV, et al. Among authors: konstantinopoulos pa. Lancet Oncol. 2009 Jul;10(7):709-17. doi: 10.1016/S1470-2045(09)70137-8. Lancet Oncol. 2009. PMID: 19573800 Review.
Matrix metalloproteinase inhibitors as anticancer agents.
Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, Papavassiliou AG. Konstantinopoulos PA, et al. Int J Biochem Cell Biol. 2008;40(6-7):1156-68. doi: 10.1016/j.biocel.2007.11.007. Epub 2007 Nov 22. Int J Biochem Cell Biol. 2008. PMID: 18164645 Review.
Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Konstantinopoulos PA, et al. Expert Opin Investig Drugs. 2007 May;16(5):569-71. doi: 10.1517/13543784.16.5.569. Expert Opin Investig Drugs. 2007. PMID: 17461732 Review.
SUMO and estrogen receptors in breast cancer.
Karamouzis MV, Konstantinopoulos PA, Badra FA, Papavassiliou AG. Karamouzis MV, et al. Among authors: konstantinopoulos pa. Breast Cancer Res Treat. 2008 Jan;107(2):195-210. doi: 10.1007/s10549-007-9552-5. Epub 2007 Mar 13. Breast Cancer Res Treat. 2008. PMID: 17377839 Review.
Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis.
Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Karamouzis MV, et al. Among authors: konstantinopoulos pa. Cell Res. 2007 Apr;17(4):324-32. doi: 10.1038/cr.2007.10. Cell Res. 2007. PMID: 17372613 Review.
Epigenomics in respiratory epithelium carcinogenesis: prevention and therapeutic challenges.
Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. Karamouzis MV, et al. Among authors: konstantinopoulos pa. Cancer Treat Rev. 2007 May;33(3):284-8. doi: 10.1016/j.ctrv.2007.01.003. Epub 2007 Mar 23. Cancer Treat Rev. 2007. PMID: 17367937 Review.
144 results
Jump to page
Feedback